ANIA ANIOL: Open Payments
NPI 1689170003 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 45 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $31 · 2025 $1,110
Food & beverage: $1,110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $320 |
| Vanda Pharmaceuticals Inc. | 11 | $238 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $108 |
| Supernus Pharmaceuticals, Inc. | 4 | $108 |
| Lundbeck LLC | 4 | $101 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 1 | $38 |
| Alkermes, Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
Products named: VRAYLAR, FANAPT, REXULTI, CAPLYTA, Qelbree, UZEDY, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
